How Fear of COVID-19 Can Affect Treatment Choices for Anaplastic Large Cell Lymphomas ALK+ Therapy: A Case Report

How Fear of COVID-19 Can Affect Treatment Choices for Anaplastic Large Cell Lymphomas ALK+ Therapy: A Case Report

Background: The t (2; 5) chromosomal rearrangement of the ALK gene with nucleophosmin 1 gene (NPM1), resulting in an NPM1–ALK fusion, was first demonstrated in 1994 in anaplastic large cell lymphoma, (ALCL), a T-cell lymphoma responsive to cyclophosphamide, abriblastine, vincristine and prednisone i...

Full description

Bibliographic Details
Main Authors: Antonello Sica, Caterina Sagnelli, Beniamino Casale, Gino Svanera, Massimiliano Creta, Armando Calogero, Renato Franco, Evangelista Sagnelli, Andrea Ronchi
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Healthcare
Subjects:
crizotinib
anaplastic large cell lymphomas ALK+
bridge therapy in NHL ALK+
ALK+ patients
anticancer therapy
Online Access:https://www.mdpi.com/2227-9032/9/2/135

Internet

https://www.mdpi.com/2227-9032/9/2/135

Similar Items